The Death Effector Domain-containing DEDD Supports S6K1 Activity via Preventing Cdk1-dependent Inhibitory Phosphorylation*

Cell cycle regulation and biochemical responses upon nutrients and growth factors are the major regulatory mechanisms for cell sizing in mammals. Recently, we identified that the death effector domain-containing DEDD impedes mitotic progression by inhibiting Cdk1 (cyclin-dependent kinase 1) and thus maintains an increase of cell size during the mitotic phase. Here we found that DEDD also associates with S6 kinase 1 (S6K1), downstream of phosphatidylinositol 3-kinase, and supports its activity by preventing inhibitory phosphorylation of S6K1 brought about by Cdk1 during the mitotic phase. DEDD-/- cells showed reduced S6K1 activity, consistently demonstrating decreased levels in activating phosphorylation at the Thr-389 site. In addition, levels of Cdk1-dependent inhibitory phosphorylation at the C terminus of S6K1 were enhanced in DEDD-/- cells and tissues. Consequently, as in S6K1-/- mice, the insulin mass within pancreatic islets was reduced in DEDD-/- mice, resulting in glucose intolerance. These findings suggest a novel cell sizing mechanism achieved by DEDD through the maintenance of S6K1 activity prior to cell division. Our results also suggest that DEDD may harbor important roles in glucose homeostasis and that its deficiency might be involved in the pathogenesis of type 2 diabetes mellitus.

[1]  P. Wright,et al.  The death domain‐containing kinase RIP1 regulates p27Kip1 levels through the PI3K–Akt–forkhead pathway , 2008, EMBO reports.

[2]  Y. Kanno,et al.  A Fas-Associated Death Domain Protein/Caspase-8-Signaling Axis Promotes S-Phase Entry and Maintains S6 Kinase Activity in T Cells Responding to IL-21 , 2007, The Journal of Immunology.

[3]  R. Quintanilla,et al.  Regulation of catalytic activity of S6 kinase 2 during cell cycle , 2007, Molecular and Cellular Biochemistry.

[4]  T. Miyazaki,et al.  Two Distinct Controls of Mitotic Cdk1/Cyclin B1 Activity Requisite for Cell Growth Prior to Cell Division , 2007, Cell cycle.

[5]  G. Thomas,et al.  mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.

[6]  Zhibo Hou,et al.  Regulation of S6 Kinase 1 Activation by Phosphorylation at Ser-411* , 2007, Journal of Biological Chemistry.

[7]  M. Kurrer,et al.  The Fas pathway is involved in pancreatic β cell secretory function , 2007, Proceedings of the National Academy of Sciences.

[8]  E. Wakeland,et al.  Death-effector domain-containing protein DEDD is an inhibitor of mitotic Cdk1/cyclin B1 , 2007, Proceedings of the National Academy of Sciences.

[9]  P. Wahl,et al.  Immunolocalization of phospho-S6 kinases: a new way to detect mitosis in tissue sections and in cell culture , 2006, Histochemistry and Cell Biology.

[10]  R. Loewith,et al.  Cell growth control: little eukaryotes make big contributions , 2006, Oncogene.

[11]  G. Thomas,et al.  Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.

[12]  K. Inoki,et al.  TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  N. Sonenberg,et al.  Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.

[14]  Mike Tyers,et al.  How Cells Coordinate Growth and Division , 2004, Current Biology.

[15]  M. Tyers,et al.  A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. , 2004, Genes & development.

[16]  S. Cooper.  Control and maintenance of mammalian cell size , 2004, BMC Cell Biology.

[17]  J. Blenis,et al.  Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy , 2004, Molecular and Cellular Biology.

[18]  J. Blenis,et al.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.

[19]  Douglas R. Kellogg,et al.  Wee1-dependent mechanisms required for coordination of cell growth and cell division , 2003, Journal of Cell Science.

[20]  Shile Huang,et al.  Targeting mTOR signaling for cancer therapy. , 2003, Current opinion in pharmacology.

[21]  S. Schreiber,et al.  Integration of growth factor and nutrient signaling: implications for cancer biology. , 2003, Molecular cell.

[22]  T. Hunter,et al.  Mitotic Regulation of Ribosomal S6 Kinase 1 Involves Ser/Thr, Pro Phosphorylation of Consensus and Non-consensus Sites by Cdc2* , 2003, The Journal of Biological Chemistry.

[23]  M. Lenardo,et al.  The death effector domain protein family: regulators of cellular homeostasis , 2003, Nature Immunology.

[24]  E. Hafen,et al.  Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. , 2003, Trends in cell biology.

[25]  I. Rupeš,et al.  Checking cell size in yeast. , 2002, Trends in genetics : TIG.

[26]  J. Blenis,et al.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.

[27]  Mike Tyers,et al.  Systematic Identification of Pathways That Couple Cell Growth and Division in Yeast , 2002, Science.

[28]  P. Vogt.  PI 3-kinase, mTOR, protein synthesis and cancer. , 2001, Trends in molecular medicine.

[29]  R. Baserga,et al.  IGF-I receptor signalling in transformation and differentiation , 2001, Molecular pathology : MP.

[30]  R. Burcelin,et al.  Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.

[31]  S. Aizawa,et al.  Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.

[32]  J. Montagne.  Genetic and molecular mechanisms of cell size control. , 2000, Molecular cell biology research communications : MCBRC.

[33]  E. Hafen,et al.  Drosophila S6 kinase: a regulator of cell size. , 1999, Science.

[34]  I. Conlon,et al.  Size Control in Animal Development , 1999, Cell.

[35]  Stefano Fumagalli,et al.  Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.

[36]  M. Peter,et al.  DEDD, a novel death effector domain‐containing protein, targeted to the nucleolus , 1998, The EMBO journal.

[37]  J. Maller,et al.  Cdc2-Cyclin B Phosphorylates p70 S6 Kinase on Ser411at Mitosis* , 1998, The Journal of Biological Chemistry.

[38]  G. Thomas,et al.  The modular phosphorylation and activation of p70s6k , 1997, FEBS letters.

[39]  R. Pearson,et al.  The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. , 1995, The EMBO journal.

[40]  J. Miyazaki,et al.  Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. , 1990, Endocrinology.